Brazilian liver cancer study reveals Real-World treatment patterns
NCT ID NCT06230328
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study reviewed medical records of 300 liver cancer patients treated in Brazil between 2017 and 2022. Researchers aimed to understand patient characteristics, how the cancer was managed, and survival outcomes. No new treatments were tested; instead, the goal was to gather real-world evidence to improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Barretos, Brazil
-
Research Site
Belo Horizonte, Brazil
-
Research Site
Curitiba, Brazil
-
Research Site
Natal, Brazil
-
Research Site
Porto Alegre, Brazil
-
Research Site
Recife, Brazil
-
Research Site
Rio de Janeiro, Brazil
-
Research Site
Salvador, Brazil
-
Research Site
São Bernardo do Campo, Brazil
-
Research Site
São Paulo, Brazil
-
Research Site
Vitória, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?